Bridget E. Bunner

Array ( [id] => 8386191 [patent_doc_number] => 08263586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'OXO bridged diazepan orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/599925 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840459 [patent_doc_number] => 20080280945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Crystalline forms of an HIV integrase inhibitor' [patent_app_type] => utility [patent_app_number] => 12/151744 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 18429 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280945.pdf [firstpage_image] =>[orig_patent_app_number] => 12151744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698933 [patent_doc_number] => 20080221117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'UREA DERIVATIVES AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/116920 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15282 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221117.pdf [firstpage_image] =>[orig_patent_app_number] => 12116920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948949 [patent_doc_number] => 20080305075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs' [patent_app_type] => utility [patent_app_number] => 12/111672 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40205 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305075.pdf [firstpage_image] =>[orig_patent_app_number] => 12111672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728089 [patent_doc_number] => 20080207633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'UREA DERIVATIVES AS CALCIUM CHANNEL BLOCKERS' [patent_app_type] => utility [patent_app_number] => 12/111131 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15292 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207633.pdf [firstpage_image] =>[orig_patent_app_number] => 12111131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813927 [patent_doc_number] => 20080194558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Quinazoline analogs as receptor Tyrosine Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/081725 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15903 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194558.pdf [firstpage_image] =>[orig_patent_app_number] => 12081725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564744 [patent_doc_number] => 20090137597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Novel quinoxalinone derivatives' [patent_app_type] => utility [patent_app_number] => 12/081773 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57715 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137597.pdf [firstpage_image] =>[orig_patent_app_number] => 12081773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417094 [patent_doc_number] => 20090042981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES' [patent_app_type] => utility [patent_app_number] => 12/105016 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20473 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042981.pdf [firstpage_image] =>[orig_patent_app_number] => 12105016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8421805 [patent_doc_number] => 08278293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-02 [patent_title] => 'Diazo bicyclic Smac mimetics and the uses thereof' [patent_app_type] => utility [patent_app_number] => 12/159249 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 37288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12159249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859092 [patent_doc_number] => 20080267942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'BENZAZEPIN-2(1H)-ONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/101317 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39563 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267942.pdf [firstpage_image] =>[orig_patent_app_number] => 12101317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603809 [patent_doc_number] => 20100063030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Benzenesulfonyl Compounds and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/595066 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21507 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063030.pdf [firstpage_image] =>[orig_patent_app_number] => 12595066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603809 [patent_doc_number] => 20100063030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Benzenesulfonyl Compounds and the Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/595066 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21507 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063030.pdf [firstpage_image] =>[orig_patent_app_number] => 12595066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162685 [patent_doc_number] => 07671082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Prodrugs of excitatory amino acids' [patent_app_type] => utility [patent_app_number] => 12/059112 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48934 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671082.pdf [firstpage_image] =>[orig_patent_app_number] => 12059112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594922 [patent_doc_number] => 20100048537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'HETEROARYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/593566 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54923 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048537.pdf [firstpage_image] =>[orig_patent_app_number] => 12593566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231353 [patent_doc_number] => 20100184645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'STITCHED POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/593384 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 44042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184645.pdf [firstpage_image] =>[orig_patent_app_number] => 12593384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615306 [patent_doc_number] => 20100099664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS' [patent_app_type] => utility [patent_app_number] => 12/531343 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29187 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099664.pdf [firstpage_image] =>[orig_patent_app_number] => 12531343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454160 [patent_doc_number] => 20100105629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV' [patent_app_type] => utility [patent_app_number] => 12/531755 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24972 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105629.pdf [firstpage_image] =>[orig_patent_app_number] => 12531755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4523999 [patent_doc_number] => 07951791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Amino-substituted tricyclic derivatives and methods of use' [patent_app_type] => utility [patent_app_number] => 12/046599 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56582 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951791.pdf [firstpage_image] =>[orig_patent_app_number] => 12046599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792737 [patent_doc_number] => 20080293711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Chemokine receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/073672 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 238786 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293711.pdf [firstpage_image] =>[orig_patent_app_number] => 12073672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774489 [patent_doc_number] => 08119669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Substituted phenoxy N-alkylated thiazolidinediones as estrogen related receptor-α modulators' [patent_app_type] => utility [patent_app_number] => 12/043291 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19528 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119669.pdf [firstpage_image] =>[orig_patent_app_number] => 12043291 [rel_patent_id] =>[rel_patent_doc_number] =>)